Drawing for EMPIRISTAT BIOSTATISTICAL SYNERGY

USPTO serial 85357991

EMPIRISTAT BIOSTATISTICAL SYNERGY

Reviewed by CopyMark Law Group

Reg. 4105186Status 710
Filing date
Status date
Registration date
Feb 28, 2012
Examiner
SEVERSON, KAREN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EMPIRISTAT BIOSTATISTICAL SYNERGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura A. Melia

LAURA A. MELIA LAURA A. MELIA, P.A.113 E CHURCH STFREDERICK, MD 21701-5403UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Providing independent review of clinical trials for business purposes; Statistical analysis and reporting services for business purposes; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Services consisting of the registration, collection, transcription, compilation and systemization of written communications and dataSECTION 8 - CANCELLEDMay 28, 2008
042Conducting research and clinical trials relating to medical devices and pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing a database in the field of clinical trials and also allowing input and collection of data and information all for research purposes; Application service provider featuring software for use in providing an online database in the field of clinical trial data to upload such data, provide statistical analysis, and produce notifications and reportsSECTION 8 - CANCELLEDMay 28, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2018C8..CANCELLED SEC. 8 (6-YR)—
Feb 28, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 28, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 13, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2011NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 9, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 9, 2011ALIEASSIGNED TO LIE—
Oct 18, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 18, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Oct 18, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 18, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 18, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 14, 2011DOCKASSIGNED TO EXAMINER—
Jul 6, 2011MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Jul 5, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 1, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance